(1S,2R)-tranylcypromine has been researched along with Leukemia, Myeloid, Acute in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lan, F; Liu, R; Xu, S; Xu, Y; Zha, X; Zhou, C; Zhu, Q | 1 |
1 other study(ies) available for (1S,2R)-tranylcypromine and Leukemia, Myeloid, Acute
Article | Year |
---|---|
Optimization of 5-arylidene barbiturates as potent, selective, reversible LSD1 inhibitors for the treatment of acute promyelocytic leukemia.
Topics: Antineoplastic Agents; Barbiturates; Cell Line, Tumor; DNA Methylation; Enzyme Inhibitors; Histone Demethylases; Humans; Inhibitory Concentration 50; Leukemia, Myeloid, Acute; Molecular Docking Simulation; Spectrum Analysis | 2018 |